{"entity":{"type":"insider","cik":"0001742485","url":"/insider/0001742485","json_url":"/insider/0001742485.json","name":"Kumar Neil","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":224,"n_filings":55,"first":"2018-06-22","last":"2026-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Kumar Neil","source":"filing","n_filings":55,"first_seen":"2018-06-22","last_seen":"2026-08-20"}],"transactions":[{"id":9299219,"accession":"0001470831-26-000848","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001470831-26-000848","line_url":"/filing/0001470831-26-000848","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001742485","owner_name":"Kumar Neil","owner_display_name":"Kumar Neil","owner_url":"/insider/0001742485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":84.025734,"price_display":"84.03","price_state":"stated","total_value":840257.34,"total_display":"840,257.34","total_whole":"840,257","shares_owned_after":505686.0,"shares_owned_after_display":"505,686","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"insider","n_lines":3},{"id":9299216,"accession":"0001470831-26-000848","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001470831-26-000848","line_url":"/filing/0001470831-26-000848","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001742485","owner_name":"Kumar Neil","owner_display_name":"Kumar Neil","owner_url":"/insider/0001742485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34980.0,"shares_display":"34,980","price_per_share":82.53269104631218,"price_display":"82.53","price_state":"stated","total_value":2886993.5328,"total_display":"2,886,993.53","total_whole":"2,886,994","shares_owned_after":243327.0,"shares_owned_after_display":"243,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-20","scope":"insider","n_lines":4},{"id":6092826,"accession":"0001470831-26-000523","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001470831-26-000523","line_url":"/filing/0001470831-26-000523","is_derivative":false,"issuer_cik":"0001742485","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001742485","owner_cik":"0001742485","owner_name":"Kumar Neil","owner_display_name":"Kumar Neil","owner_url":"/insider/0001742485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":67.8769349625,"price_display":"67.88","price_state":"stated","total_value":2715077.3985,"total_display":"2,715,077.40","total_whole":"2,715,077","shares_owned_after":4322862.0,"shares_owned_after_display":"4,322,862","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-05","filed_date":"2026-06-08","scope":"insider","n_lines":6},{"id":6092804,"accession":"0001470831-26-000523","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001470831-26-000523","line_url":"/filing/0001470831-26-000523","is_derivative":false,"issuer_cik":"0001742485","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001742485","owner_cik":"0001742485","owner_name":"Kumar Neil","owner_display_name":"Kumar Neil","owner_url":"/insider/0001742485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":67.4552844875,"price_display":"67.46","price_state":"stated","total_value":2698211.3795,"total_display":"2,698,211.38","total_whole":"2,698,211","shares_owned_after":536136.0,"shares_owned_after_display":"536,136","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-08","scope":"insider","n_lines":8},{"id":5980562,"accession":"0001470831-26-000488","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001470831-26-000488","line_url":"/filing/0001470831-26-000488","is_derivative":false,"issuer_cik":"0001742485","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001742485","owner_cik":"0001742485","owner_name":"Kumar Neil","owner_display_name":"Kumar Neil","owner_url":"/insider/0001742485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26103.0,"shares_display":"26,103","price_per_share":69.43729692755622,"price_display":"69.44","price_state":"stated","total_value":1812521.7617,"total_display":"1,812,521.76","total_whole":"1,812,522","shares_owned_after":244127.0,"shares_owned_after_display":"244,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-21","filed_date":"2026-05-26","scope":"insider","n_lines":5},{"id":5946757,"accession":"0001470831-26-000423","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001470831-26-000423","line_url":"/filing/0001470831-26-000423","is_derivative":false,"issuer_cik":"0001742485","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001742485","owner_cik":"0001742485","owner_name":"Kumar Neil","owner_display_name":"Kumar Neil","owner_url":"/insider/0001742485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":66.907525375,"price_display":"66.91","price_state":"stated","total_value":2676301.015,"total_display":"2,676,301.02","total_whole":"2,676,301","shares_owned_after":4364473.0,"shares_owned_after_display":"4,364,473","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-08","filed_date":"2026-05-11","scope":"insider","n_lines":6},{"id":5946747,"accession":"0001470831-26-000423","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001470831-26-000423","line_url":"/filing/0001470831-26-000423","is_derivative":false,"issuer_cik":"0001742485","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001742485","owner_cik":"0001742485","owner_name":"Kumar Neil","owner_display_name":"Kumar Neil","owner_url":"/insider/0001742485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":67.8985599925,"price_display":"67.90","price_state":"stated","total_value":2715942.3997,"total_display":"2,715,942.40","total_whole":"2,715,942","shares_owned_after":584469.0,"shares_owned_after_display":"584,469","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-07","filed_date":"2026-05-11","scope":"insider","n_lines":6},{"id":5881246,"accession":"0001470831-26-000361","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001470831-26-000361","line_url":"/filing/0001470831-26-000361","is_derivative":false,"issuer_cik":"0001742485","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001742485","owner_cik":"0001742485","owner_name":"Kumar Neil","owner_display_name":"Kumar Neil","owner_url":"/insider/0001742485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":74.6043,"price_display":"74.60","price_state":"stated","total_value":2984172.0,"total_display":"2,984,172.00","total_whole":"2,984,172","shares_owned_after":595686.0,"shares_owned_after_display":"595,686","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-10","filed_date":"2026-04-13","scope":"insider","n_lines":2},{"id":5881242,"accession":"0001470831-26-000361","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001470831-26-000361","line_url":"/filing/0001470831-26-000361","is_derivative":false,"issuer_cik":"0001742485","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001742485","owner_cik":"0001742485","owner_name":"Kumar Neil","owner_display_name":"Kumar Neil","owner_url":"/insider/0001742485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":74.61520244,"price_display":"74.62","price_state":"stated","total_value":2984608.0976,"total_display":"2,984,608.10","total_whole":"2,984,608","shares_owned_after":4418447.0,"shares_owned_after_display":"4,418,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-09","filed_date":"2026-04-13","scope":"insider","n_lines":6},{"id":6038321,"accession":"0001470831-26-000275","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001470831-26-000275","line_url":"/filing/0001470831-26-000275","is_derivative":false,"issuer_cik":"0001742485","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001742485","owner_cik":"0001742485","owner_name":"Kumar Neil","owner_display_name":"Kumar Neil","owner_url":"/insider/0001742485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":68.7950781575,"price_display":"68.80","price_state":"stated","total_value":2751803.1263,"total_display":"2,751,803.13","total_whole":"2,751,803","shares_owned_after":635686.0,"shares_owned_after_display":"635,686","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-16","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":"2026-03-13|6038313","ledger_fault":false,"count":{"value":224,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":214,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":224},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001743881","name":"BridgeBio Pharma, Inc.","url":"/issuer/0001743881","role":"Director, Officer (Chief Executive Officer)","n_filings":51,"first_seen":"2020-01-06","last_seen":"2026-08-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001731831","name":"Eidos Therapeutics, Inc.","url":"/issuer/0001731831","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":4,"first_seen":"2018-06-22","last_seen":"2019-07-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001742485","retrieved_at":"2026-08-22T21:00:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}